Why is Vadivarhe Speci. falling/rising?
As of 12-Nov, Vadivarhe Speciality Chemicals Ltd's stock price is Rs. 20.90, down 5.0%, marking a new 52-week low and a 55.53% decline over the past year. The company shows weak fundamentals with high debt and negative EBITDA, contrasting sharply with the broader market's growth.
As of 12-Nov, Vadivarhe Speciality Chemicals Ltd is experiencing a decline in its stock price, currently at Rs. 20.90, which represents a decrease of 1.1 or 5.0%. The stock has hit a new 52-week low today and has underperformed its sector by 6.08%. Over the past week, the stock has decreased by 5.00%, and it has shown a significant decline of 55.53% over the past year. The company has not declared results in the last six months, indicating weak long-term fundamental strength, and it has a high Debt to EBITDA ratio of -1.00 times, which suggests low ability to service debt. Additionally, the stock has generated a negative EBITDA and has seen a drastic profit decline of 299% over the past year, contributing to its poor performance.In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 1.09% over the past week and 9.44% year-to-date. This indicates that while the overall market is experiencing growth, Vadivarhe Speciality Chemicals Ltd is struggling significantly. The stock's trading is below all its moving averages, and there has been a notable decrease in investor participation, with delivery volume falling by 33.33% against the five-day average. This combination of factors has led to a lack of confidence among investors, further driving the stock price down.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
